Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 141 results for "Qualitest Pharmaceuticals"

Endo to Acquire Par Pharmaceutical, Strategically Expanding Ge...

/CNW/ -- Endo International plc "Our generics business, Qualitest, continues to be an extremely attractive and effective growth driver for Endo. This transaction with Par builds upon our generics growth, adding a strong portfolio of high ... Bloomberg, 1 week ago
Endo Expands Generics Biz, Pays $5B for Par Pharma Pharmaceutical Manufacturing Magazine, 1 week ago

Endo Vaults Into Top 5 Among Generic-Drug Firms

Aspiring specialty-drug giant Endo International agreed to buy major generic-drug maker Par Pharmaceutical Holdings for $8.05 billion Monday, a deal that Endo says will make it one of the top five generic-drug makers in the world. Investors were ...
 Yahoo! Singapore1 week ago Endo Buying Par Pharma To Become Top Generics Player  Investor's Business Daily1 week ago

May 18 Premarket Briefing: 10 Things You Should Know

1. -- U.S. stock futures were drooping as investors considered rising oil prices and news of a big pharmaceutical deal by Endo after last week's volatile market moves. European stockswere mixed Monday, torn between hopes that the U.S. Federal ...
 Yahoo! Singapore1 week ago

Endo buying Par for $8B to boost generic sales, profit margins amid industry consolidation

TRENTON, N.J. - Drugmaker Endo International PLC is climbing toward the top of the steadily consolidating generic medicine business with a deal to buy Par Pharmaceutical Holdings Inc. for about $8.05 billion. The deal would enable Dublin-based ...
 Castanet.net1 week ago Endo buying Par for $8b in push for generics, higher profit  Boston Globe1 week ago

ENDO INTERNATIONAL PLC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

The following Management's Discussion and Analysis of Financial Condition and Results of Operations describes the principal factors affecting the results of operations, liquidity and capital resources and critical accounting estimates at Endo ...
 Pharmacy Choice2 weeks ago

Endo International, a New Position for OZ Management

OZ Management's Five New Positions in 4Q14 (Part 4 of 6) ( Continued from Part 3 ) OZ Management's holdings in Endo International In the fourth quarter, Oz Management added a new stake in Endo International plc (ENDP) by purchasing 5,221,710 ...
 Yahoo! Finance1 month ago

World CNS Therapeutics Industry

/PRNewswire/ -- This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants, and Others. The ...
 Fat Pitch Financials1 month ago

Enforcement Report for March 18, 2015

Devices Pressure IQ Evolve Mattress; Non-powered mattress replacement system. Intended for patients with medium to high risk for developing pressure ulcers while on a mattress. All Pressure IQ Evolve mattresses ...
 U.S. Food and Drug Administration2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less